Related Experiment Video
Updated: Dec 5, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
[Mooren's ulcer]
E A Kasparova1, E I Krasnolutskaya1, E M Kruglova1
1Research Institute of Eye Diseases, Moscow, Russia.
Abstract:
The article reviews available data on Mooren's ulcer - a rare disease of, supposedly, autoimmune origin that manifests as peripheral ulceration of the cornea and poses a risk of its perforation. The variability of clinical presentation and course of the disease often leads to misdiagnosis and inadequate treatment. The present review focuses on specific signs characteristic of the disease and the most effective methods of its treatment.
Insights
Mooren's ulcer, a rare autoimmune corneal disease, presents with peripheral ulceration. This review highlights characteristic signs and effective treatments for this condition to improve diagnosis and patient outcomes.
Area of Science:
- Ophthalmology
- Autoimmune Diseases
- Corneal Pathology
Background:
- Mooren's ulcer is a rare peripheral ulcerative keratitis.
- Its presumed autoimmune origin contributes to diagnostic challenges.
- Variability in presentation and disease course often results in misdiagnosis.
Purpose of the Study:
- To review available data on Mooren's ulcer.
- To identify characteristic clinical signs of the disease.
- To summarize the most effective treatment modalities.
Main Methods:
- Literature review of available data on Mooren's ulcer.
- Analysis of clinical presentation and disease course.
- Evaluation of treatment efficacy based on existing studies.
Main Results:
- Mooren's ulcer exhibits variable clinical presentations.
- Characteristic signs aiding diagnosis were identified.
- Effective treatment strategies were summarized.
Conclusions:
- Accurate diagnosis of Mooren's ulcer requires recognition of specific clinical signs.
- Timely and appropriate treatment is crucial to prevent corneal perforation.
- Further research may elucidate the autoimmune mechanisms involved.
More Related Videos
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
08:51Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
Published on: August 24, 2019
Related Concept Videos
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease